Nasdaq

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
Nasdaq

BD Submits PMA Supplement To FDA For ThinPrep Pap Test PreservCyt Solution Vial - Quick Facts

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ...
Seeking Alpha

BD submits pre-market approval supplement for use of ThinPrep Pap Test PreservCyt solution with HPV assay

Becton, Dickinson or BD (BDX +2.0%) has submitted a pre-market approval (PMA) supplement to FDA for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its ...
Reuters

FDA approves first HPV test with SurePath preservative fluid

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
Becker's Hospital Review

Roche’s new HPV test earns FDA approval

The Food and Drug Administration approved the Roche cobas HPV Test to detect human papilloma virus through the use of cervical cells collected for a Pap test and stored in SurePath Preservative Fluid.